It seems insulin production and beta cell functioning may persist despite the onset of Type 1 diabetes, according to research conducted at the Massachusetts General Hospital and published in the March issue of Diabetes Care.
Self-monitoring blood glucose levels in Type 2 diabetics not on an insulin regimen may contribute little to managing the disease, according to an analysis published online last month by The Cochran Library.
In an effort to help advance the development of devices that automatically monitor blood glucose and provide proper insulin doses in people with Type 1 diabetes, the Food and Drug Administration has issued draft guidance to help investigators and manufacturers as they develop and seek approval for these products.
The Juvenile Diabetes Research Foundation and InnoCentive are calling for innovative ways to approach the discovery and development of a glucose-responsive insulin drug as a means to treat Type 1 diabetes.
More evidence may be needed to support research that implied that atmospheric pressure during airplane travel could influence the effectiveness of insulin pump devices, according to an editorial published in Diabetes Technology & Therapeutics.